The SUSTAIN-6 trial, a landmark study, revealed that semaglutide significantly reduced the risk of major adverse cardiovascular events, including heart attack, stroke, and cardiovascular death, compared to placebo
Researchers also believe that manipulating cAMP signaling could eventually help address the weight loss plateaus that many people experience while using GLP-1 therapies
People with a history of medullary thyroid cancer, gallbladder disease, or pancreatitis should not take semaglutide
However, many doctors still hesitate to prescribe these medications, and insurance coverage remains inconsistent
What side effects might signal a thyroid problem during semaglutide treatment
Ordinarily, in someone who has not lost weight on Ozempic-type drugs, if theres a complication [related to healing] after surgery, we see it as early as week two, and we tend to see good healing between weeks four and six. But for GLP-1 patients, incisions will sometimes reopen in spots